Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
7.170
+0.090 (+1.27%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Medicine (MindMed) Inc. - Common Shares
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
July 01, 2025
From
FN Media Group LLC
Via
GlobeNewswire
MindMed Announces New Employee Inducement Grants
June 09, 2025
From
Mind Medicine Inc.
Via
Business Wire
Earnings Scheduled For May 8, 2025
May 08, 2025
Via
Benzinga
New Study Shows Ibogaine Can Be Made Without Using Plant Matter
February 18, 2025
Via
Investor Brand Network
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
July 01, 2025
EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Why Mind Medicine Gave Investors a Powerful Buzz in May
June 04, 2025
Via
The Motley Fool
Topics
Law Enforcement
MindMed to Participate in June Investor Conferences
May 28, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer
May 27, 2025
From
Mind Medicine Inc.
Via
Business Wire
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
May 24, 2025
Psychedelics litigator Matthew Zorn joins HHS under RFK Jr. to lead policy. What it means for CMPS, MNMD, CYBN, PSIL & more.
Via
Benzinga
Topics
Government
Why Mind Medicine Stock Vaulted More Than 8% Higher Today
May 20, 2025
Via
The Motley Fool
Let's uncover which stocks are experiencing notable gaps during today's session.
May 20, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via
Chartmill
Agilysys, Amer Sports, X Financial And Other Big Stocks Moving Higher On Tuesday
May 20, 2025
Via
Benzinga
MindMed Announces New Employee Inducement Grants
May 19, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference
May 13, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates
May 08, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed to Report First Quarter 2025 Financial Results on May 8, 2025
April 24, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces New Employee Inducement Grants
April 21, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD)
April 15, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
The Future of Healthcare: 10 Predictions For The Next Decade
March 27, 2025
The healthcare industry stands on the brink of a transformative decade, driven by rapid advancements in technology, shifting demographics, and evolving patient expectations. Over the next ten years, we...
Via
MarketMinute
Topics
Artificial Intelligence
MindMed Announces New Employee Inducement Grants
March 24, 2025
From
Mind Medicine Inc.
Via
Business Wire
Study Finds That the Mental Wellbeing Effects of Psilocybin Vary by Race
March 17, 2025
Via
Investor Brand Network
MindMed Appoints Matt Wiley as Chief Commercial Officer
March 17, 2025
From
Mind Medicine Inc.
Via
Business Wire
Gap To Rally Over 69%? Here Are 10 Top Analyst Forecasts For Friday
March 07, 2025
Via
Benzinga
Mind Medicine's Net Losses Swell In Q4, But Retail Finds At Least 3 Reasons To Stay Bullish
March 06, 2025
The psychedelics treatment developer reported a net loss of $34.7 million for the quarter ended Dec. 31, 2024, widening from a $23.8 million loss a year earlier.
Via
Stocktwits
MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates
March 06, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed to Present at Leerink’s Global Healthcare Conference 2025
March 04, 2025
From
Mind Medicine Inc.
Via
Business Wire
Earnings Scheduled For March 6, 2025
March 06, 2025
Via
Benzinga
Warren Buffett's State of the Market
March 03, 2025
Berkshire's cash hoard is approaching "Dr. Evil" levels.
Via
The Motley Fool
Groups of Military Veterans Urge Congress to Expedite Research on Psychedelics
March 03, 2025
Via
Investor Brand Network
Topics
Cannabis
MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
February 20, 2025
From
Mind Medicine Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
33
34
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.